2016 News + Events

Intraop® Mobetron® Accelerates Breast Cancer Care for More Than 7,500 Patients Worldwide

Milestone indicates intraoperative radiation therapy (IORT) with electrons is gaining momentum as a treatment option for women with breast cancer SUNNYVALE, Calif. – IntraOp Medical Corporation today announced that more than 7,500 women with breast cancer have been treated with the IntraOp® Mobetron®, an intraoperative radiation therapy (IORT) device used to deliver a precise, cancer-killing … Continued

Read More
2015 News + Events

IntraOp Mobetron Electron IORT System to Nanjing General Hospital

Dr. Zhu Xixu, Director of the Department of Radiation Oncology at NGH. “Electron IORT has demonstrated significant benefits in the treatment of locally advanced and recurrent cancers as well early stage breast cancer. The Mobetron expands our ability to treat these cancers and ensures our patients have access to the best possible treatment options to aid their fight against cancer.”

Read More

IntraOp Sponsors School of Oncoplastic Surgery in Dallas January 22-24 2016

IntraOp Medical is proudly sponsoring the School of Oncoplastic Surgery Dallas January 22-24, 2016 Didactic lectures Full day cadaver lab Evening sculpture lab One on one with expert faculty Live models for surgical markings Enhance and learn new surgical skills Networking with faculty & colleagues Featuring new technologies in the lab Learn about coding for … Continued

Read More

APBI vs. WBI : The Results are Clear

The GEC-ESTRO Phase III trial validates the oncologic concept of APBI. The results of the GEC-ESTRO phase III trial comparing APBI versus WBI are significant and potentially practice changing in that they indicate for the first time (in a large, well-designed, contemporary phase III trial with adequate follow-up) that the scientific concept of treating only the lumpectomy cavity (plus a proper margin) is just as effective and safe as treating the whole breast in selected patients with early stage breast cancer.

Read More